« New Berkeley Lab spectroscopy technique for in situ measurement of charge dynamics in an operating battery electrode | Main | GM investing $24M in electrical generation equipment to use more landfill gas at two plants »
Evonik investigating bacterial conversion of syngas to specialty chemicals; 2-HIBA demo
5 December 2013
Evonik Industries has demonstrated the use of bacteria to convert syngas to pure 2-hydroxyisobutyric acid (2-HIBA) under industrial conditions. 2-HIBA is a precursor used in the manufacture of PLEXIGLAS. Waste gas is one example of a source of syngas.
2-HIBA can also be produced via chemical synthesis. Both the chemically-produced and biotech-produced products can be converted to methyl methacrylate (MMA). MMA is used in paints, varnishes, and anti-rust coatings, as well as in soft contact lenses and dental implants. Poly(methyl methacrylate) (PLEXIGLAS) is used for creating sheets, profiles, roofs, soundproof walls, molded components for automotive engineering applications, and backlight units for illuminating flat-screen monitors and televisions. Evonik is one of the largest producers of MMA.
In addition to 2-HIBA for the plastics industry, other products could include their derivatives for the cosmetics industry, or C4 alcohols for the paints and varnishes industry.
For the ability to convert carbon monoxide, carbon dioxide, and hydrogen—the components of syngas—into more valuable molecules, Evonik looked to bacteria from earth’s earliest history—to a time when oxygen was not yet present in earth’s atmosphere. Certain microorganisms today still contain the genetic information for these processes. Evonik has used their enzymes to create a cell factory that generates specialty chemicals from syngas.
Evonik scientists are now working to optimize these ideas and develop them still further.
We have a long way to go before we can use bacteria for converting syngas to high-quality specialty chemicals on a large industrial scale. It will still take a couple of years until it is ready for the market.—Dr. Thomas Haas, head of Biotechnology at Creavis, Evonik’s strategic innovation unit
Evonik views biotechnology as a field with tremendous potential for innovation. The specialty chemicals manufacturer is already using biotech methods to produce high-quality products. These first-generation industrial biotechnology processes involve the use of plant oils, grains, and sugars as raw materials for fermentation. Evonik uses these materials to produce amino acids and cosmetic ingredients, among other products.
The first second-generation biotechnology plants are currently under construction, and these utilize residual plant materials from agriculture and forestry. Evonik is only pursuing a few projects in this area, and is instead focusing more of its attention on third-generation biotechnology.
We’re exploring third-generation biotechnology, because in addition to sugar or residual plant materials converted to syngas, waste from other sources such as municipal waste and industrial waste gas can also serve as raw materials. That makes us less dependent not only on fossil-based raw materials, but also on renewable resources that could potentially compete with the food supply.—Thomas Haas
Following a resolution passed by the German Bundestag, this research is partly funded by the Federal Ministry of Food, Agriculture and Consumer Protection.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Evonik investigating bacterial conversion of syngas to specialty chemicals; 2-HIBA demo: